It is now widely recognized that neutrophils are highly versatile and sophisticated cells that display de novo synthetic capacity and may greatly extend their lifespan. In addition, concepts such as "neutrophil heterogeneity" and "neutrophil plasticity" have started to emerge, implying that, under pathological conditions, neutrophils may differentiate into discrete subsets defined by distinct phenotypic and functional profiles. A number of studies have shown that neutrophils act as effectors in both innate and adaptive immunoregulatory networks. In fact, once recruited into inflamed tissues, neutrophils engage into complex bidirectional interactions with macrophages, natural killer, dendritic and mesenchymal stem cells, B and T lymphocytes or platelets. As a result of this crosstalk, mediated either by contact-dependent mechanisms or cellderived soluble factors, neutrophils and target cells reciprocally modulate their survival and activation status. Altogether, these novel aspects of neutrophil biology have shed a new light not only on the potential complex roles that neutrophils play during inflammation and immune responses, but also in the pathogenesis of several inflammatory disorders including infection, autoimmunity and cancer.
INTRODUCTION
Over the past two decades, hundreds of reports have clearly documented that neutrophils are highly versatile and sophisticated cells, whose functions go far beyond the elimination of microorganisms. New fascinating aspects of typical activities, as well as novel and unanticipated functions, have been recently attributed to neutrophils. In this context, the notion that the average circulatory lifespan of neutrophils results much longer than previously thought, 1 and that their longevity increases several fold during inflammation, 2 has changed the view under which these cells have for long been considered. Accordingly, during their persistence in tissues, neutrophils can exert complex activities, including the orchestration of the immune response. [3] [4] [5] [6] [7] In addition, during the late, final phases of acute inflammatory responses, neutrophils become involved in the active induction of inflammation resolution through the production of pro-resolving lipid mediators. 8 Moreover, the findings that neutrophils are also capable of "reverse" transmigration add another dimension to our understanding of the possible fates of these cells once they have migrated into inflamed tissues. 7 Among unanticipated findings, concepts such as "neutrophil heterogeneity" and "neutrophil plasticity" have also started to emerge. [9] [10] [11] [12] The notion that neutrophils are able to shape the inflammatory/immune responses through de novo production of cytokines and a release of preformed proinflammatory mediators, such as proteases and alarmins, is also now well established. 13 Finally, the observation that neutrophils can infiltrate lymphoid organs, including spleen and lymph nodes, as well as the demonstration that neutrophils exhibit complex crosstalk with components of the innate and adaptive immune system, which may contribute to the pathogenesis of numerous chronic inflammatory disorders, has renewed interest in these cells within the immunology community. [3] [4] [5] [6] [7] For personal use only. on June 4, 2017 . by guest www.bloodjournal.org From
In this article, we mostly focus on human neutrophils and summarize the recent findings on their heterogeneity and plasticity, as well as on the role that these cells play in linking the innate and adaptive arms of the immune response and in driving immune-mediated pathologies.
Observations recently generated in mouse models will be also described when offering novel information on neutrophil functions.
NEUTROPHIL HETEROGENEITY
Evidence for the existence of neutrophil subsets with functional and phenotypic heterogeneity has recently emerged in both humans and mice. 7, 12 For instance, small fractions of human neutrophils have been reported to express selected molecules under both physiological and pathological conditions, including T cell receptor (TCR)-associated variable immunoreceptor, 14 or olfactomedin 4, 12, 15 or neutrophil antigen B1 (NB1/CD177), 12,16-17 or CD49d. 18 Similarly, while senescent neutrophils express elevated levels of CXCR4, neutrophils undergoing reverse transendothelial cell migration express elevated levels of intercellular adhesion molecule-1 (ICAM-1) and low levels of CXCR1. 7, 12 However, the biological and functional implications of these observations remain mostly unclear.
On the other hand, detection of distinct circulating subsets displaying neutrophil-like morphology and showing immunosuppressive or proinflammatory functions has been well documented in systemic inflammation, autoimmune diseases or cancer. [9] [10] [11] Some of these within total leukocytes simply obtained by red cell lysis of whole blood (arbitrarily named here as "unfractionated" neutrophils, "UNs", Figure 1B) . Notably, while all these neutrophil populations display a neutrophil-like morphology and the specific granulocyte marker CD66b, their phenotype, maturation/activation status, as well as function, result different depending on the disease type. [9] [10] [11] Such "heterogeneity", particularly observed in immunosuppressive subsets, could derive, at least in part, from the fact that both immature and in vivo activated neutrophils display altered buoyancy and sediment within the PBMC fraction ( Figure 1A ). In addition, it has been recently shown that, in HIV patients, a subset of immunosuppressive neutrophils, characterized by markedly elevated levels of surface programmed death receptor 1 ligand (PDL-1), are recovered as both PDL-1 high LDNs and PDL-1 high NDNs after density gradient centrifugation. 19 These observations would suggest that certain phenotypic/functional changes, instead of being intrinsic features of specialized neutrophil subsets, might occur in total circulating neutrophils as a result of systemic inflammation. Clearly, this issue might be solved when a careful comparison among UNs, LDNs and NDNs from the same diseased individuals is performed.
Low-density neutrophil (LDN) subsets
LDNs have been detected not only in patients with autoimmune disorders, 11 sepsis, 20 HIV infections 19, 21 and cancer, 10 but also in patients with graft-versus-host disease undergoing extracorporeal photopheresis treatments, 22 pregnant women 23 or in healthy donors receiving granulocyte-colony stimulating factor (G-CSF) for stem cell mobilization. 24-25 LDNs described in sepsis seem to be mostly immature and functionally poorly characterized ( Figure 1A ).
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For personal use only. on June 4, 2017. by guest www.bloodjournal.org From LDNs isolated from patients suffering from autoimmune diseases, such as systemic lupus erythematosus (SLE) and psoriasis, have been instead more recently defined as "low-density granulocytes" (LDGs) ( Figure 1A ) and mostly consist of a mixed population of immature and mature cells with neutrophil-like morphology. 11 LDGs display proinflammatory functions and induce vascular damage via their enhanced ability to release of inflammatory molecules and autoantigens, as well as of neutrophil extracellular traps (NETs, which result from the extrusion of nuclear DNA together with antimicrobial proteins 26 ). 11 By contrast, LDNs identified in solid tumor, G-CSF-treated donors or HIV patients are generally defined as "granulocytic myeloidderived suppressor cells (G-MDSCs)" due to their immunosuppressive functions ( Figure   1A ). 10, 19, 21, [24] [25] Confusion still exists on the phenotype of G-MDSCs, with some reports describing these cells as "activated", while others as "immature" cells with neutrophil-like morphology. 10 The immunosuppressive function exerted by G-MDSCs is mainly defined according to their ability to suppress T cell activation/proliferation and it has been shown to be primarily mediated by overproduction of arginase 1 and/or reactive oxygen species (ROS). 10 It should be pointed out that the relationship existing among G-MDSCs and the other identified immunosuppressive neutrophil subsets (see below) is a matter of extensive investigation in the field. [9] [10] Indeed, whether G-MDSCs are specialized subsets of neutrophils or originate through an altered process of granulopoiesis is still unclear. 10 The recent observations that monocytic MDSC (Mo-MDSCs) can differentiate into G-MDSCs in tumor-bearing mice and in patients with multiple myeloma 27 have further complicated the scenario. It has been also suggested that splenic granulocyte and macrophage progenitors are significantly increased in patients with invasive cancer. 28 The fact that freshly isolated splenic neutrophils from healthy donors were shown to inhibit the proliferation of CD4 + T cells 29 raises the possibility that, similar to mice, human G-MDSCs might originate through a process of inflammation-induced extramedullary granulopoiesis.
Other neutrophil immunosuppressive subsets
To date, several NDNs inhibiting T cell proliferation through diverse mechanisms have been identified (Figure 1A) 
NEUTROPHIL PLASTICITY
The concept that neutrophils may display a previously unanticipated plasticity derives from observations on their ability, under inflammatory settings, to differentiate into other myeloid cell types. Accordingly, the fact that neutrophils can acquire antigen presenting (APC)-like properties and dendritic cell (DC) characteristics upon long-term incubation with discrete cytokine combinations, or be reprogrammed into macrophages, has been known for a long time. Table 1) . 3, 50 Evidence that NK cells may instead induce neutrophil apoptosis under specific co-culture conditions, either via NKp46-and Fas-dependent mechanisms or via interactions between NKG2D and MHC class I chain-related molecule A, also exist in the literature (Table 1) . Reciprocally, neutrophils modulate NK cell survival, proliferation, cytotoxic activity and production of IFNγ, via the generation of prostaglandins or ROS, through release of granule components or via contact-dependent mechanisms ( Table 1) . 3, 50 In addition, recent observations suggest that, by releasing EVs, neutrophils negatively modulate NK cell functions, in particular skewing NK-derived cytokines from a proinflammatory to an
For personal use only. on June 4, 2017. by guest www.bloodjournal.org From anti-inflammatory profile. 51 The relevance of the in vitro findings on crosstalk between human neutrophils and NK cells has been highlighted by studies proving that, under steady state, neutrophils are crucial for NK cell development in both humans and mice. 52 Additional evidence that crosstalk between these two cell types can also occur in vivo has recently been shown in a mouse model of systemic fungal infection, in which a IL-17-NK cell-GM-CSF axis was found to be critical for the modulation of neutrophil fungicidal activity. 53 In line with these findings, in vitro co-culture of human NK cells and neutrophils in the presence of Candida albicans resulted in a NK-mediated enhancement of neutrophil antifungal activity, concomitantly with a neutrophil-mediated inhibition of NK cell activation, 54 suggesting that interactions between these two cell types might serve to reciprocally modulate their responses.
Neutrophils and innate lymphoid cell types (ILCs). Mucosal tissues contain a large number of
innate lymphocytes now collectively referred to as ILCs. 55 Evidence has been emerging that the various ILC subsets play a key role in the orchestration of immunity to infection and in the pathogenesis of allergic and autoimmune diseases. 55 In this context, a recently described human splenic ILC subset, with mucosa-like properties, has been found to activate marginal zone (MZ) B cells, either directly via B Cell Activating Factor (BAFF), CD40 ligand and Delta-like 1 production, or indirectly, by producing GM-CSF. The latter cytokine, in turn, has been shown to potentiate the ability of splenic neutrophils to directly activate B-cell functions. 56 It is likely that additional crosstalk between neutrophils and other ILC subsets will be soon uncovered. Table 2 ).
Neutrophils and T cells. The ability of both naïve/polarized T cells and neutrophils to
reciprocally influence their effector functions under co-culture conditions, either via chemokine and cytokine production or contact-dependent mechanisms, have been extensively discussed in previous reviews 3,5-6,61 ( Table 2 and Supplemental Table 2 ). Earlier studies, however, had already uncovered that T cell-derived cytokines, particularly IFNγ, GM-CSF and TNFα, function as "priming" agents for human neutrophils, namely as factors able to greatly enhance neutrophil functions, either indirectly, via DC activation, or directly, through chemokine/cytokine production, APC-like properties or NET-mediated mechanisms. [3] [4] [5] However, since several studies also suggest that, as described above, activated neutrophils or neutrophil subsets have a predominantly suppressive function on T cells, [9] [10] it is clear that the outcome of neutrophil-T cell crosstalk is a function of the experimental settings during which these interactions occur ( Table   2 and Supplemental Table 2 ).
Controversial observations are emerging on the crosstalk occurring between human neutrophils and γδ T cells. Although initial evidence suggested that γδ T cells are involved in neutrophil killing to limit host tissue damage during sepsis, more recent studies report that γδ T cells positively modulate neutrophil recruitment, activation and survival ( Finally, neutrophils have been shown to impair iNKT cell function, in both mice and humans, through cell-cell contact dependent mechanisms ( Table 2 and Supplemental Table 2 ).
NEUTROPHILS IN DISEASES
Most of our knowledge on neutrophil functions in human diseases derives from correlative studies on cells isolated from patients. However, since isolation procedures, cell purity or drug treatment these patients are receiving, often limit the reliability of the observations made, the role of neutrophils in disease pathogenesis is mostly extrapolated from studies in experimental animal models. . 83 In such regard, the description of surface TLR9 in neutrophils points for additional mechanisms whereby neutrophils could sense microbial derived hypomethylated CpG DNA. 84 Similarly, TLR4, the receptor for LPS, was shown to function, in neutrophils, also as receptor for shiga toxin, 85 
Neutrophils in cancer
Recent reviews elegantly discuss the multiple (pro-and anti-tumor) roles of neutrophils in cancer. 59,107-108 Current evidence mostly support the idea that neutrophils facilitate, rather than inhibit, cancer progression primarily through their ability to promote tumor angiogenesis, invasion and metastasis. [107] [108] [109] [110] This concept is also supported by dozens of reports correlating elevated numbers of tumor-infiltrating and/or blood neutrophils, as well as elevated blood neutrophil/lymphocyte ratios, with poor clinical outcome in several cancers. 111 The mechanisms whereby neutrophils contribute to cancer metastasis, in particular, have recently gained more attention. For instance, even NETs have been involved in metastasis, by both trapping cancer cells and favouring their dissemination through the microvasculature. 112 Histopathological evaluation of biopsies from a small cohort of pediatric patients with Ewing sarcoma (ES) has indeed revealed the presence of tumor-associated neutrophils (TANs) undergoing NETosis in samples from patients with metastasis. 113 In this context, we have shown that metastatic tumor-draining lymph nodes from carcinoma patients infiltrated by slanDCs also contain, in some cases, CD66b + neutrophils within an immunosuppressed like microenvironment. 114 A very recent observation in a head and neck cancer model suggests that neutrophils, previously exposed to tumor-conditioned medium, induce an invasive, NK-resistant and highly metastatic tumor cell phenotype (Brandau S., et al. unpublished data, 2014). Another mechanism proposed to explain pro-tumor activities by human and mouse TANs consists in their ability to recruit regulatory T cells (Tregs) to the tumor sites, via CCL17 release. 115 Based on all these findings, inducing the conversion of neutrophils from pro-tumor to anti-tumor cells may represent a new form of immunotherapy for cancer. 116 In this context, because neutrophils are the most abundant population of circulating white blood cells expressing FcγR and FcαR able to execute potent cytotoxic functions, the possibility of exploiting neutrophils for antibody-based cancer immunotherapy holds significant promise and deserves further investigation.
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CONCLUDING REMARKS
It is now beyond doubt that the traditional view of neutrophils as short-lived effector cells with limited functional capacity is incomplete. Neutrophils display many more functions than previously suspected, including the capacity to influence regulatory circuits in the innate and adaptive immune systems. The increasing availability of experimental animal models, including the zebrafish system, which allows prompt genetic and chemical manipulation, 118 will provide new approaches to expand our knowledge of neutrophil biology.
As mentioned, an additional way whereby neutrophils may orchestrate, under physiological and pathological conditions, the evolution of inflammation, immune response, hematopoiesis, wound healing, angiogenesis, tissue remodeling and bone reabsorption, occurs via the production and release of cytokines. 13 In this context, as our technologies become more powerful and new molecules are cloned, the number of cytokines and chemokines that neutrophils can potentially produce continues to expand (Table 3) , in some cases being regulated in a neutrophil-specific manner. 13, 57, 59 While the molecular mechanisms underlying the peculiar regulation of cytokine expression in neutrophils remain to be defined, recent studies suggest that they may include neutrophil-specific chromatin organization programs. 119 Future challenges for scientists in the field will be to translate all these new insights into efficacious neutrophiltargeted therapies for the treatment of inflammatory conditions without compromising immunity. Figure 1A) , or the total leukocytes (obtained after red cell lysis of whole blood) from healthy volunteers administered with endotoxin or from patients with severe injury, cancer or HIV infection (arbitrarily indicated as "unfractionated" neutrophils, "UNs" in Figure 1B ). For 
